ArticleScientific reports2018

Cinacalcet use and the risk of cardiovascular events, fractures and mortality in chronic kidney disease patients with secondary hyperparathyroidism.

Marie Evans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.